Published in Biomed Khim on September 24, 2014
Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997. Emerg Infect Dis (2001) 1.26
Specific fragmentation of tRNA and rRNA at a 7-methylguanine residue in the presence of methylated carrier RNA. Eur J Biochem (1985) 1.03
Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes. Protein Sci (2001) 1.00
Mutations in the proteolytic domain of Escherichia coli protease Lon impair the ATPase activity of the enzyme. FEBS Lett (1998) 0.96
Effect of changes in ambient pH on phosphorylation of cellular proteins. Dokl Biochem Biophys (2006) 0.90
Mechanism of pepsin catalysis: general base catalysis by the active-site carboxylate ion. FEBS Lett (1978) 0.88
Studies on the mechanisms of action of proteolytic enzymes using heavy oxygen exchange. Eur J Biochem (1981) 0.85
Interplay between folding/unfolding and helix/coil transitions in giant DNA. Biomacromolecules (2000) 0.84
The isolated proteolytic domain of Escherichia coli ATP-dependent protease Lon exhibits the peptidase activity. FEBS Lett (1998) 0.83
Deficient Response to Experimentally Induced Alkalosis in Mice with the Inactivated insrr Gene. Acta Naturae (2011) 0.82
[Interferon inhibition of the development of a staphylococcal infection]. Antibiot Med Biotekhnol (1985) 0.82
Autolysis of bovine enteropeptidase heavy chain: evidence of fragment 118-465 involvement in trypsinogen activation. FEBS Lett (1999) 0.82
[Effect of interferon type I on the in vivo persistence of Salmonella typhimurium]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.81
Relationship between structure and histamine releasing action of polymyxin B and its analogues. Agents Actions (1990) 0.81
[Entrapment of herbal extracts in biodegradable microcapsules]. Biomed Khim (2008) 0.81
Monoclonal antibodies directed to the synthetic carbohydrate antigen Ley. Hybridoma (1994) 0.80
Structural features of the interfaces in enzyme-inhibitor complexes. J Biomol Struct Dyn (2010) 0.80
HIV-I protease. Cloning, expression, and purification. Appl Biochem Biotechnol (1997) 0.80
Kinetics of pepsin-catalysed transpeptidation: evidence for the 'amino-enzyme' intermediate. FEBS Lett (1974) 0.80
An enzyme-linked lectin assay for alpha1,3-galactosyltransferase. Anal Biochem (2000) 0.80
[Keratinase of an anaerobic thermophilic bacterium Thermoanaerobacter sp. strain 1004-09 isolated from a hot spring in the Baikal Rift zone]. Mikrobiologiia (2009) 0.78
[Multilocus sequence-typing for characterization of Moscow strains of Haemophilus influenzae type b]. Mol Gen Mikrobiol Virusol (2003) 0.78
A new approach to establishing the set of phages for typing methicillin-resistant Staphylococcus aureus. J Chemother (1991) 0.78
[Role of the α-helical domains in the functioning of ATP-dependent Lon protease of Escherichia coli]. Bioorg Khim (2015) 0.78
Study of secondary specificity of enteropeptidase in comparison with trypsin. Biochemistry (Mosc) (2004) 0.77
Mucoadjuvant properties of lipo- and glycoconjugated derivatives of oligochitosans. Eur J Med Chem (2008) 0.77
Chemical studies on actinoxanthin. J Antibiot (Tokyo) (1976) 0.77
[Biodegradable polymer microparticles with entraped herbal extracts: preparation with supercritical carbon dioxide and use for tissue repair]. Biomed Khim (2009) 0.77
Solid-phase assays for study of carbohydrate specificity of galectins. Biochemistry (Mosc) (2010) 0.77
[Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine]. Klin Lab Diagn (1995) 0.77
Stabilization of proteases by entrapment in a new composite hydrogel. Appl Biochem Biotechnol (1997) 0.77
[Hydrolysis by enteropeptidase of nonspecific (model) peptide sequences and possible physiological role of this phenomenon]. Vopr Med Khim (2003) 0.76
[Isolation and determination of activity of IgA1 protease from Neisseria meningitidis]. Bioorg Khim (2010) 0.76
[Development of a rapid method for the detection of prostate-specific antigen by immunochromatography]. Bioorg Khim (2007) 0.76
Oligopeptidase B from Serratia proteamaculans. I. Determination of primary structure, isolation, and purification of wild-type and recombinant enzyme variants. Biochemistry (Mosc) (2009) 0.76
[Isolation and characteristics of galactose-binding lectins from human blood serum]. Bioorg Khim (1996) 0.75
Psychrophilic trypsin-type protease from Serratia proteamaculans. Biochemistry (Mosc) (2006) 0.75
[Monitoring for Neisseria meningitidis species using sequencing of variable fragments of surface proteins FetA and PorA genes]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Antitoxic activity of interferon preparations]. Antibiot Med Biotekhnol (1985) 0.75
[Drug resistant staphylococci in surgical departments]. Khirurgiia (Mosk) (1972) 0.75
[Action of inhibitors of the energy processes on the efficiency of staphylococcal phage infection]. Mol Gen Mikrobiol Virusol (1986) 0.75
[Methods for detecting drug-resistant staphylococci in the human body under natural conditions]. Antibiotiki (1975) 0.75
[Vi antigen and microbial adhesion factors. The detection of adhesins in commercial Vi antigen preparations]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Molecular biological characteristics of staphylococcal plasmids]. Antibiotiki (1984) 0.75
[A comparative study of the immunogenicity of 2 group-B meningococcal vaccines in monkeys]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Staphylococcus aureus phages]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration]. Zh Mikrobiol Epidemiol Immunobiol (1995) 0.75
[Action of different interferon preparations on pathogenic microorganisms]. Mikrobiol Zh (1983) 0.75
[The immunomodulating action of microwaves in the induction of an immune response to Vi antigen]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[Interferon preparations in the complex treatment of bacterial infections]. Antibiot Khimioter (1989) 0.75
[Changes in the bactericidal activity of macrophages from mice with various degrees of resistance to Salmonella typhimurium infection as affected by interferon]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Specific binding of kanamycin by Mycobactrium tuberculosis after its contact with body tissues]. Antibiotiki (1968) 0.75
[Continuous synchronously dividing cultures of the B meningococcus serogroup]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Cleavage of tRNA and rRNA at 7-methylguanine in the presence of methylated carrier RNA]. Biokhimiia (1984) 0.75
[Effect of the synthetic preparation B 58 on the activity of natural killer and cytostatic cells of the mouse spleen]. Biull Eksp Biol Med (1987) 0.75
[Effect of proflavin on the chemotherapeutic activity of isoniazid and streptomycin in albino mice with experimental tuberculosis]. Probl Tuberk (1970) 0.75
[Effects of trypsin and the products of trypsinization of the liver, lung and spleen on the sensitivity of Mycobacterium tuberculosis to chemotherapeutic substances]. Probl Tuberk (1967) 0.75
[Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[The diagnostic value of a meningococcal-B erythrocyte diagnostic agent based on the group-specific polysaccharide]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Effect of penicillin on the intensity of formation of penicillin-resistant staphylococcal populations in the suppurative foci of patients]. Antibiotiki (1975) 0.75
[Epidemiological mechanism for the formation of drug-resistant bacterial populations]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Resistance of Shigella to antibiotics]. Antibiotiki (1974) 0.75
[Role of lysogenizing phages in the spread of drug-resistance plasmids in a staphylococcal population]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Antistaphylococcal activity in interferon preparations]. Antibiotiki (1982) 0.75
[Protective properties of Vi-antigen preparations as dependent on their adhesin content]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Effect of certain compounds on the transmission of extrachromosomal determinants of drug resistance in staphylococci]. Zh Mikrobiol Epidemiol Immunobiol (1970) 0.75
[Transmission of extrachromosomal drug resistance in staphylococci present in animals and the effect of neomycin on this process]. Antibiotiki (1970) 0.75
[Interferon and bacterial infections]. Antibiot Med Biotekhnol (1987) 0.75
[Distribution of carriers of resistant Staphylococcus strains among healthy persons and its connection with the use of antibiotics]. Antibiotiki (1970) 0.75
[Effect of periods in the use of antibiotics on the formation rate of drug-resistant Staphylococcal populations in patients]. Antibiotiki (1973) 0.75
[The effect of detergents on the immunological activity of the antigens of Neisseria meningitidis serogroup B[]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[The role of adhesin in the polymeric structure of Vi-antigen]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[Reactogenicity of a group A and C meningococcal polysaccharide bivalent vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[The immunological status indices of monkeys inoculated with a meningococcal B vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Methicillin-resistant Staphylococci]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice]. Antibiotiki (1968) 0.75
[The sorption of a protein-polysaccharide complex isolated from Neisseria meningitidis serogroup B on aluminum hydroxide gels and the immunological activity of the sorbed preparations]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Effect of interferon type I on staphylococcal persistence and indices of body immunoreactivity]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Immunologic properties of purified and complex preparations of group-B meningococcal polysaccharide]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Isolation and characteristics of a specific polysaccharide of group-B meningococci]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Increasing the antibacterial action of antitubercular agents through the use of acridine derivatives]. Probl Tuberk (1969) 0.75
[Effect of interferon on the absorption of staphylococci by the macrophages of mouse peritoneal exudate]. Mikrobiol Zh (1989) 0.75
[Dynamics of the antibiotic sensitivity of the staphylococci in suppurative, inflammatory foci in patients during the period of the hospital stay]. Antibiotiki (1975) 0.75
[Interferon enhances the bactericidal activity of peritoneal exudate macrophages against Salmonella typhimurium in mice]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75
[Theoretical substantiation of methods for limiting the circulation of drug-resistant staphylococci]. Antibiotiki (1984) 0.75
[Role of antibiotics used under various conditions of air semination with drug resistant Staphylococci in the formation of resistant microbial populations in the human organism]. Antibiotiki (1972) 0.75
[A system for the mass combined vaccination of the adult population against influenza, viral hepatitis, typhoid, meningitis and diphtheria]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Method of determining the sensitivity of Staphylococcus aureus to methicillin]. Antibiotiki (1976) 0.75
[Interferon activation of the production of a factor increasing the bactericidal properties of mouse macrophages]. Biull Eksp Biol Med (1988) 0.75
[Enhanced activity of the protective factors in patients with suppurative surgical infection using interferon preparations]. Antibiot Med Biotekhnol (1985) 0.75
[Transmissivity of drug resistance in Salmonella]. Antibiotiki (1975) 0.75
[Transmissivity of the various R factors found among E. coli cultures circulating under natural conditions]. Antibiotiki (1975) 0.75
Association between phage DNA injection and generation of the protonmotive force in Staphylococcus aureus. Zentralbl Bakteriol (1989) 0.75
[The reactogenicity and antigenic activity of a meningococcal group B vaccine made from a natural complex of the specific polysaccharide and outer membrane proteins]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75